Surgical Science Sweden AB
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SUSRF research report →
About the company
Surgical Science Sweden AB engages in the development of simulators for laparoscopic medical training. Its products include LapSim, for procedural simulation for cholecystectomy, appendectomy, advanced suturing and anastomosis, gynecology, hysterectomy, bariatrics, and nephrectomy; EndoSim, for endoscopy simulation; and TeamSim, for realistic training of collaboration within a surgery team. The company was founded by Anders Hyltander, David Löfstrand, and Anders Larsson on July 24, 1997 and is headquartered in Gothenburg, Sweden.
- CEO
- Tom Englund
- IPO
- 2021
- Employees
- 313
- HQ
- Gothenburg, AB, SE
Price Chart
- Market Cap
- $204.10M
- P/E
- 31.22
- P/S
- 1.68
- P/B
- 0.37
- EV/EBITDA
- 6.21
- Div Yield
- 0.00%
- Gross Margin
- 63.12%
- Op Margin
- 7.65%
- Net Margin
- 5.34%
- ROE
- 1.21%
- ROIC
- 1.14%
- Revenue
- $989.85M · 11.96%
- Net Income
- $66.65M · -49.37%
- EPS
- $1.29 · -50.00%
- Op Income
- $108.70M
- FCF YoY
- -24.25%
- 52W High
- $15.47
- 52W Low
- $2.84
- 50D MA
- $3.59
- 200D MA
- $4.52
- Beta
- 0.60
- Avg Volume
- 6
Get TickerSpark's AI analysis on SUSRF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our SUSRF coverage
Recent articles, reports, and earnings notes.
No research on SUSRF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SUSRF report →Similar companies
Peers in the same neighborhood.